Our findings showed that obesity-induced dysbiosis exacerbated IFN-γ production and pulmonary inflammation in M. tuberculosis infection, and led to understanding of GLA and obesity-induced dysbiosis, which might reveal targets for the treatment of pulmonary inflammatory diseases, such as host-directed therapies for severe tuberculosis. This evidence concerns the gene IFNG and inflammation.